Concord Drugs Limited Share Price

Concord Drugs Limited Share Price

BSE: 538965
|
Pharmaceuticals
|
S Cap
₹ 79.11
+₹5.11 (6.91%)
1D
Last updated 23 Sep, 2026, 15:55 IST

Concord Drugs Limited Share Price Today

As of 23 Sep 2026, Concord Drugs Limited share price is ₹79.11. The stock opened at ₹76.89, compared to its previous close of ₹74.00. During today's trading session, Concord Drugs Limited share price moved in the range of ₹76.89 to ₹79.50, with an average price of ₹78.19 for the day. Looking at its last 52-week, the stock has touched a low of ₹61.00 and a high of ₹92.52.

₹76.89
6.91% up today
₹79.50
1D LOW
1D HIGH

Concord Drugs Limited Returns Calculator

Circuit
L
H
₹59.20
₹88.80
52-week
L
H
₹61.00
₹92.52

About Concord Drugs Limited

Concord Drugs Limited Share Price
ISIN
INE858L01010
Sector Market Cap
₹ 98.77 Cr

Concord Drugs Limited is an India-based pharmaceutical company. The Company's principal activity is to manufacture licensed drugs based on the formulations approved. The Company is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modified release pellets. It operates a Current Good Manufacturing Practice (cGMP) contract manufacturing formulation-fill-finish facility, offering a full spectrum of pharmaceutical development and manufacturing services for drug products. The Company's products include pharmaceutical ready to fill pellets, MUPS; tissue bio adhesive; injectables (small volume parenterals); oral solid dosages (tablets); oral solid dosages (capsules); liquid orals, and dry syrup (powder). It also offers hand sanitizers under the brand name, PROTON SAFE. It manufactures hand sanitizers on third party basis also. The Company's oral liquid dosage forms include solutions, syrups, and suspensions.

Concord Drugs Limited Financial Highlights

  • Revenue: Concord Drugs Limited reported revenue of ₹78.77 crore in FY26 vs ₹45.26 crore in FY25. It showed an increase of 74.04% on a yearly basis.
  • Operating Profit: Concord Drugs Limited reported an operating profit of ₹1.47 crore in FY26 vs ₹0.69 crore in FY25. It showed an increase of 113.04% on a year-on-year basis.
  • Net Profit: Concord Drugs Limited reported a net profit of ₹1.06 crore in FY26 vs ₹0.34 crore in FY25. It showed an increase of 211.76% on a yearly basis.

Concord Drugs Limited Quarterly Result Highlights

  • Concord Drugs Limited reported revenue of ₹20.95 crore in Jun 2026, compared with ₹37.90 crore in Mar 2026, representing a decrease of 44.72% on a quarter-on-quarter (QoQ) basis.
  • Concord Drugs Limited reported an operating profit of ₹1.54 crore in Jun 2026, compared with ₹0.75 crore in Mar 2026, representing an increase of 105.33% on a quarter-on-quarter (QoQ) basis.
  • Concord Drugs Limited reported a profit of ₹1.11 crore in Jun 2026, compared with ₹0.53 crore in Mar 2026, reflecting an increase of 109.43% on a QoQ basis.
  • The earnings per share (EPS) of Concord Drugs Limited stood at ₹0.95 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
45.08%
FII
0.00%
Other DII
0.00%
Retail and other
54.92%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Nov 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
97.50
P/E
47.44
P/B
2.09
ROE
2.17%
D/E
0.24
ROCE
5.12%
Div. Yield
0.00%
EPS(TTM)
0.93
Turnover
1.16
EV/EBITDA
19.30
Net Margin
1.37%
Op. Margin
5.63%
ROA
2.74%
Quick Ratio
1.73
Curr. Ratio
6.02
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Concord Drugs outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Concord Drugs appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Concord Drugs revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Concord Drugs Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹78.74₹45.24₹44.92₹52.08
Other Income₹0.03₹0.01₹0.01₹0.01
Total Revenue₹78.77₹45.26₹44.93₹52.09
Total Expenses₹77.30₹44.57₹44.30₹50.84
Profit Before Tax₹1.47₹0.69₹0.63₹1.25
Tax₹0.42₹0.36₹0.16₹0.26
Profit After Tax₹1.06₹0.34₹0.47₹0.99
EPS - Basic₹0.95₹0.34₹0.47₹1.06
EPS - Diluted₹0.95₹0.34₹0.47₹1.06

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1.47₹0.69₹0.63₹1.25
Income before WC changes₹4.52₹4.13₹4.04₹4.51
Change in Assets-₹9.81-₹5.50-₹1.10₹6.21
Change in Liabilities-₹0.04₹5.29-₹1.93-₹8.67
Change in WC-₹9.85-₹0.21-₹3.03-₹2.46
Cash flow from Operations-₹5.75₹3.72₹0.79₹1.66
Cash flow from Investing-₹1.13-₹2.32-₹1.01-₹2.27
Cash flow from Financing₹7.04-₹1.43₹0.28₹0.62
Total Cash Flow₹0.16-₹0.02₹0.07₹0.02
Cash (Start of the year)₹0.12₹0.15₹0.08₹0.06
Cash (End of the year)₹0.28₹0.12₹0.15₹0.08

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹21.58₹24.38₹21.29₹14.77
Current Assets₹53.31₹40.76₹37.52₹43.46
Total Assets₹74.89₹65.14₹58.81₹58.23
Current Liabilities₹21.07₹25.16₹21.00₹21.61
Net Current Asset₹32.24₹15.60₹16.51₹21.84
Non-Current Liabilities₹5.31₹5.87₹3.98₹4.91
Equity Capital₹48.51₹34.11₹33.82₹31.70
Total Equity & Liabilities₹74.89₹65.14₹58.81₹58.23

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹75.85₹36.93₹43.26₹51.31
Other Income₹0.03₹0.01₹0.01₹0.01
Total Revenue₹75.88₹36.95₹43.27₹51.32
Total Expenses₹74.43₹36.31₹42.71₹50.20
Profit Before Tax₹1.45₹0.64₹0.56₹1.13
Tax₹0.41₹0.35₹0.14₹0.23
Profit After Tax₹1.04₹0.30₹0.42₹0.89
EPS - Basic₹0.93₹0.30₹0.42₹0.96
EPS - Diluted₹0.93₹0.30₹0.42₹0.96

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1.45₹0.64₹0.56₹1.13
Income before WC changes₹4.23₹3.76₹3.68₹4.28
Change in Assets-₹13.31-₹1.39₹0.08₹0.51
Change in Liabilities₹3.27-₹0.15-₹1.59-₹2.20
Change in WC-₹10.04-₹1.54-₹1.51-₹1.68
Cash flow from Operations-₹6.22₹2.04₹1.96₹2.24
Cash flow from Investing-₹1.13-₹2.32-₹1.21-₹2.27
Cash flow from Financing₹7.51₹0.26-₹0.69₹0.05
Total Cash Flow₹0.16-₹0.02₹0.06₹0.03
Cash (Start of the year)₹0.12₹0.14₹0.08₹0.04
Cash (End of the year)₹0.27₹0.12₹0.14₹0.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹22.38₹25.16₹22.01₹15.23
Current Assets₹49.47₹33.42₹34.28₹41.40
Total Assets₹71.85₹58.58₹56.30₹56.63
Current Liabilities₹18.02₹18.61₹19.11₹20.90
Net Current Asset₹31.45₹14.82₹15.18₹20.50
Non-Current Liabilities₹5.32₹5.86₹3.37₹4.03
Equity Capital₹48.51₹34.11₹33.82₹31.70
Total Equity & Liabilities₹71.85₹58.58₹56.30₹56.63
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
78.9
645
79.11
361
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1006
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
41.05
Neutral
ATR (14)
4.03
Neutral
STOCH(9,6)
8.6
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
41.56
Bearish
UO(9)
38.04
Neutral
ROC(12)
-7.86
Bearish
WillR(14)
-92.52
Bullish
Period
Simple value
Exponential vaue
5D
76.12
75.82
10D
78.03
77.07
20D
79.06
77.37
50D
74.68
76.46
100D
76.86
76.55
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Concord Drugs Limited Share Price
Concord Drugs Limited
Pharmaceuticals
Add Stock
Add Another

Concord Drugs Limited Share Price FAQs

Concord Drugs Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837